Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-10-189742
Filing Date
2010-08-16
Accepted
2010-08-16 11:13:38
Documents
8
Period of Report
2009-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1751855
2 SECTION 302 CERTIFICATION OF CEO dex311.htm EX-31.1 10302
3 SECTION 302 CERTIFICATION OF CFO dex312.htm EX-31.2 10151
4 SECTION 906 CERTIFICATION OF CEO dex321.htm EX-32.1 3259
5 SECTION 906 CERTIFICATION OF CFO dex322.htm EX-32.2 3116
6 GRAPHIC g88214tx_pg010.jpg GRAPHIC 57630
7 GRAPHIC g88214tx_pg015.jpg GRAPHIC 92062
8 GRAPHIC g88214tx_pg019.jpg GRAPHIC 120741
  Complete submission text file 0001193125-10-189742.txt   2153114
Mailing Address 324 SOUTH HYDE PARK AVE SUITE 350 TAMPA FL 33606
Business Address 324 SOUTH HYDE PARK AVE SUITE 350 TAMPA FL 33606 8138642562
ACCENTIA BIOPHARMACEUTICALS INC (Filer) CIK: 0001310094 (see all company filings)

EIN.: 000000000
Type: 10-K | Act: 34 | File No.: 000-51383 | Film No.: 101017819
SIC: 2834 Pharmaceutical Preparations